Among the complicated molecular responses to radiation in cancer cells, activation of the RAS/PI3K/AKT pathway results in resistance to radiation therapy[17]–[19] and synthetic PI3K inhibitors radio-sensitize some cancer cells including malignant glioma[20]–[22]. The gene discussed is AKT1; the disease is cancer.